Showing results (31-40 of 368) with videos related to

Sort By:
Pageof 37
Anticancer Research|November 10, 2019
PRAME Expression as a Potential Biomarker for Hematogenous Recurrence of Esophageal Squamous Cell CarcinomaHayato Baba, Mitsuro Kanda, Koichi Sawaki, et al.
British Journal of Cancer|January 11, 2023
A liquid biopsy signature for predicting early recurrence in patients with gastric cancerKeisuke Okuno, Shuichi Watanabe, Souvick Roy, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|May 6, 2019
The levels of SYT13 and CEA mRNAs in peritoneal lavages predict the peritoneal recurrence of gastric cancerKoki Nakanishi, Mitsuro Kanda, Shinichi Umeda, et al.
Annals of Surgical Oncology|June 15, 2019
Risk Prediction of Postoperative Pneumonia After Subtotal Esophagectomy Based on Preoperative Serum Cholinesterase ConcentrationsMitsuro Kanda, Masahiko Koike, Chie Tanaka, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|August 27, 2024
Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric cancerMitsuro Kanda, Nao Takano, Hiroshi Miyauchi, et al.
Anticancer Research|September 16, 2016
Correlation Between Poor Prognosis and Lower TPPP Gene Expression in Hepatocellular CarcinomaYoshikuni Inokawa, Fuminori Sonohara, Mitsuro Kanda, et al.
Asian Journal of Endoscopic Surgery|September 2, 2022
Preoperative indocyanine green fluorescence injection to accurately determine a proximal margin during robotic distal gastrectomyKoki Nakanishi, Chie Tanaka, Mitsuro Kanda, et al.
Annals of Surgical Oncology|September 20, 2022
Gamma-aminobutyric Acid Type A Receptor Subunit Delta as a Potential Therapeutic Target in Gastric CancerKoichi Sawaki, Mitsuro Kanda, Hayato Baba, et al.
Pageof 37